NO20010166L - Pharmaceutical applications of NAB1 and NAB2 - Google Patents

Pharmaceutical applications of NAB1 and NAB2

Info

Publication number
NO20010166L
NO20010166L NO20010166A NO20010166A NO20010166L NO 20010166 L NO20010166 L NO 20010166L NO 20010166 A NO20010166 A NO 20010166A NO 20010166 A NO20010166 A NO 20010166A NO 20010166 L NO20010166 L NO 20010166L
Authority
NO
Norway
Prior art keywords
nab1
nab2
pharmaceutical applications
pharmaceutical
applications
Prior art date
Application number
NO20010166A
Other languages
Norwegian (no)
Other versions
NO20010166D0 (en
Inventor
Martin Braddock
Callum Jeffrey Campbell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9814989.1A external-priority patent/GB9814989D0/en
Priority claimed from GBGB9819826.0A external-priority patent/GB9819826D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20010166D0 publication Critical patent/NO20010166D0/en
Publication of NO20010166L publication Critical patent/NO20010166L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20010166A 1998-07-11 2001-01-10 Pharmaceutical applications of NAB1 and NAB2 NO20010166L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9814989.1A GB9814989D0 (en) 1998-07-11 1998-07-11 Gene therapy method
GBGB9819826.0A GB9819826D0 (en) 1998-09-12 1998-09-12 Gene therapy method
PCT/GB1999/002199 WO2000003014A1 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of nab1 and nab2

Publications (2)

Publication Number Publication Date
NO20010166D0 NO20010166D0 (en) 2001-01-10
NO20010166L true NO20010166L (en) 2001-03-06

Family

ID=26314007

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010166A NO20010166L (en) 1998-07-11 2001-01-10 Pharmaceutical applications of NAB1 and NAB2

Country Status (22)

Country Link
EP (1) EP1097200A1 (en)
JP (1) JP2002520020A (en)
KR (1) KR20010071832A (en)
CN (1) CN1317045A (en)
AP (1) AP2001002038A0 (en)
AU (1) AU763713B2 (en)
BR (1) BR9912018A (en)
CA (1) CA2336805A1 (en)
EA (1) EA200100028A1 (en)
EE (1) EE200100020A (en)
HR (1) HRP20010025A2 (en)
HU (1) HUP0102835A3 (en)
ID (1) ID27742A (en)
IL (1) IL140533A0 (en)
IS (1) IS5788A (en)
NO (1) NO20010166L (en)
NZ (1) NZ509174A (en)
PL (1) PL345507A1 (en)
SK (1) SK382001A3 (en)
TR (1) TR200100622T2 (en)
WO (1) WO2000003014A1 (en)
YU (1) YU1901A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928430D0 (en) * 1999-12-01 2000-01-26 Glaxo Group Ltd Screening
AU2001291019A1 (en) 2000-09-15 2002-03-26 Genvec, Inc. Method of modulating neovascularization
WO2004083435A1 (en) * 2003-03-17 2004-09-30 Julius-Maximilians-Uni Versität Würzburg Nab proteins and their use in diagnostic and therapeutic applications in heart disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5697901A (en) * 1989-12-14 1997-12-16 Elof Eriksson Gene delivery by microneedle injection

Also Published As

Publication number Publication date
IS5788A (en) 2000-12-22
PL345507A1 (en) 2001-12-17
EA200100028A1 (en) 2001-08-27
AP2001002038A0 (en) 2001-03-31
JP2002520020A (en) 2002-07-09
NO20010166D0 (en) 2001-01-10
AU4791499A (en) 2000-02-01
AU763713B2 (en) 2003-07-31
EP1097200A1 (en) 2001-05-09
EE200100020A (en) 2002-06-17
IL140533A0 (en) 2002-02-10
YU1901A (en) 2005-06-10
CN1317045A (en) 2001-10-10
CA2336805A1 (en) 2000-01-20
HUP0102835A3 (en) 2003-09-29
WO2000003014A1 (en) 2000-01-20
NZ509174A (en) 2003-08-29
HUP0102835A2 (en) 2001-11-28
KR20010071832A (en) 2001-07-31
BR9912018A (en) 2006-01-31
HRP20010025A2 (en) 2001-12-31
TR200100622T2 (en) 2001-10-22
ID27742A (en) 2001-04-26
SK382001A3 (en) 2001-09-11

Similar Documents

Publication Publication Date Title
DE838021T1 (en) ELECTRONIC MEDICAL THERMOMETER
DK0817626T3 (en) Use of fumagillol and its derivatives for the manufacture of drugs for intestinal infections
NO20011496L (en) Initiation of explosive devices
DE69908021T2 (en) Ziprasidone-containing medicines
NO984094D0 (en) Discharge reactor and use of the same
NO20004752D0 (en) Multilayer plastic pipes and use of the same
NO993731L (en) Pyrrolopyrazolopyrimidine compound and medicine comprising this
DE59409323D1 (en) Flat structure element and packing formed from it
NO983678D0 (en) New cephemic compounds and pharmaceutical applications thereof
DE69718077T2 (en) Medicines consisting of diclofenac
DE69529848D1 (en) ELECTRONIC MEDICAL THERMOMETER
NO995406L (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
NO20010166D0 (en) Pharmaceutical applications of NAB1 and NAB2
NO20010685D0 (en) New pharmaceutical applications of NOS inhibitors
NO20016345D0 (en) Emulsions of surfactants and structured systems of surfactants
NO20014454D0 (en) Construction and application of the same
NO974966D0 (en) New applications of heptafluoropropane
NO20005022L (en) Inhibition of the binding of hox and homeodome-containing proteins and their applications
NO20010470D0 (en) Switching device and use of the same
FR2782606B1 (en) FOOD FLOUR AND ITS APPLICATIONS
KR980000670U (en) External discharge device of rice
KR970060188U (en) Assembly structure of electronic products
FR2818982B1 (en) SPECIFIC INHIBITOR OF THE UBIQUITINE-PROTEASOME SYSTEM AND CORRESPONDING THERAPEUTIC APPLICATIONS
KR970042238U (en) Screw terminal structure of ring terminal of electronic products
UA2674S (en) ELEMENT OF JEWELRY

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application